<DOC>
<DOCNO>
EP-0003269
</DOCNO>
<TEXT>
<DATE>
19790808
</DATE>
<IPC-CLASSIFICATIONS>
C07D-491/22 C07D-491/00 C07D-471/22 C07D-471/00 
</IPC-CLASSIFICATIONS>
<TITLE>
pentacyclic derivatives, process for their preparation and pharmaceutical compositions containing them.
</TITLE>
<APPLICANT>
science union & ciefr<sep>science union et cie societe francaise de recherche medicale<sep>science union et cie societe francaise de recherche medicale14 rue du val d'orf-92150 suresnesfr  <sep>
</APPLICANT>
<INVENTOR>
offner edouardfr<sep>offner, edouard<sep>offner, edouardles tilleuls vattetot sous beaumontf-76110 godervillefr<sep>
</INVENTOR>
<ABSTRACT>
heteroyohimbanecarboxylic acid derivatives of formula <image>  in which  r' denotes a methoxy radical  r denotes hydrogen or methyl  z denotes oxygen or an imino or methylimino radical  x denotes a lower alkoxy radical, an amino group or hydrogen  n denotes 0, 1 or 2 m denotes 0 and in this case x is hydrogen or m denotes 1 and in this case x is hydrogen, an alkoxy radical or an amino radical and a denotes oxygen or an imido radical, and the n-oxides, quaternary ammonium salts and salts with an organic inorganic acid.  the compounds are prepared by reacting a functional derivative heteroyohimbane-16-carboxylic acid with a hydrozine of formula <image> the compounds have pharmacological properties which make them suitable for use as an active principle of medication, especially against hypertension and peripheral cardiac or circulatory insufficiency. 
</ABSTRACT>
</TEXT>
</DOC>
